Your browser doesn't support javascript.
loading
Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine.
Mashimo, Yoichi; Yamazaki, Keiko; Kageyama, Takahiro; Tanaka, Shigeru; Taniguchi, Toshibumi; Matsushita, Kazuyuki; Igari, Hidetoshi; Hanaoka, Hideki; Yokote, Koutaro; Nakajima, Hiroshi; Onouchi, Yoshihiro.
Afiliação
  • Mashimo Y; Department of Public Health, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Yamazaki K; Department of Public Health, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Kageyama T; Department of Allergy and Clinical Immunology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Tanaka S; Department of Allergy and Clinical Immunology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Taniguchi T; Department of Infectious Diseases, Chiba University Hospital, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan; Chiba University Hospital COVID-19 Vaccine Center, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Matsushita K; Division of Laboratory Medicine, Chiba University Hospital, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Igari H; Department of Infectious Diseases, Chiba University Hospital, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan; Chiba University Hospital COVID-19 Vaccine Center, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Hanaoka H; Clinical Research Center, Chiba University Hospital, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Yokote K; Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Nakajima H; Department of Allergy and Clinical Immunology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan; Chiba University Hospital COVID-19 Vaccine Center, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.
  • Onouchi Y; Department of Public Health, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan. Electronic address: onouchy@chiba-u.jp.
J Infect ; 85(6): 702-769, 2022 12.
Article em En | MEDLINE | ID: mdl-36341890
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM